Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 8;15(3):e009195. doi: 10.1161/CIRCHEARTFAILURE.121.009195

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 The Authors.

Circulation: Heart Failure is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.

PMC Copyright notice

Figure 6. — TA1 at 60 nmol/L achieves similar rate-pressure product (RPP) at higher developed pressure (DevP), wall stress and lower heart rate (HR), and left ventricular end diastolic pressure (LVEDP) compared with 120 nmol/L dobutamine (Dob), with neutral effect on ATP synthesis rate.

A through E, During magnetization transfer, 60 nmol/L TA1 achieved higher DevP and wall stress (A and C), lower LVEDP (D) and HR (B), and similar RPP (E) compared with 120 nmol/L Dob. ATP synthesis rate was similar between the groups. F, n=9 (in 60 nmol/L TA1 group) and 10 (in 120 nmol/L Dob group). Data shown are mean±SEM. P values were obtained by unpaired t tests. *P<0.05 and **P<0.01, respectively. w.w. indicates wet weight.